Serotonin Syndrome Following Methylene Blue Administration for Vasoplegic Syndrome | Zendy

Hencken Laura | Zendy; To Long | Zendy; Ly Nancy | Zendy; Morgan Jeffrey A. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Serotonin Syndrome Following Methylene Blue Administration for Vasoplegic Syndrome

Author(s) -

Hencken Laura,

To Long,

Ly Nancy,

Morgan Jeffrey A.

Publication year - 2016

Publication title -

journal of cardiac surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.428

H-Index - 58

eISSN - 1540-8191

pISSN - 0886-0440

DOI - 10.1111/jocs.12705

Subject(s) - medicine , serotonin syndrome , serotonin , serotonergic , methylene blue , anesthesia , refractory (planetary science) , receptor , photocatalysis , astrobiology , catalysis , biochemistry , chemistry , physics

Methylene blue (MB) has been used for additional blood pressure support in patients who develop severe, refractory vasoplegia; however, MB can induce serotonin syndrome, especially when used in conjunction with other serotonergic agents. We describe a case of serotonin syndrome in a patient who received MB for vasoplegic syndrome after left ventricular assist device implantation and discuss its presentation and management. doi: 10.1111/jocs.12705 (J Card Surg 2016;31:208–210)

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research